In a recent joint regulatory statement, Ohio's trifecta of healthcare overseers — comprising the State Medical Board of Ohio, the Ohio Board of Pharmacy, and the Ohio Board of Nursing — has collectively sounded the alarm about the burgeoning industry of retail IV therapy clinics. These clinics have been aggressively pitching their IV concoctions as quick fixes for hangovers, dehydration, and a raft of other maladies. These establishments, particularly in the Cincinnati area, tout their blends of saline, vitamins, electrolytes, amino acids, and medications as superior solutions for bolstering immunity, gut health, and joint function.
Amid the circulation of these concerns, Dr. Michael (Mick) Schoech from the University of Cincinnati delved into the subject during an interview on Cincinnati Edition on 91.7 WVXU News. Schoech, who serves as an associate professor in the Division of Digestive Diseases and director of UC Health's transplant hepatology program questioned the efficacy of IV therapy for treating hangovers, noting that such a condition stems from a complex interplay of dehydration, plunging blood alcohol levels, and a body crying out for rest, and languor; the provided IV drip addresses dehydration only, it will not hasten the body's detoxification processes nor alleviate a headache, fatigue, nausea, anxiety, sensitivity to light and sound, and poor concentration faster than nature's course.
While the promise of quick relief is alluring, the medical community's voice interpolates a narrative of caution; as the consumer-driven wellness market burgeons without the bridle of stringent regulation, Ohio's medical regulators are thus calling attention to the potential for these retail IV outlets to peddle more placebo than panacea, the efficacy of their treatments for the advertised purposes, without the support of robust clinical evidence, remains an open question.
